The identification of the mobilized colistin resistance gene *mcr*-*1* recently attracted extensive attention from the scientific community. MCR-1 confers resistance to polymyxins, a group of polypeptide antibiotics that are currently considered the last refuge of therapeutics against lethal challenges by Gram-negative pathogens with multi-drug resistance \[[@CR1], [@CR2]\]. Very recently, two separate groups reported the co-occurrence of MCR-1 and extended-spectrum β-lactamase (ESBL) on plasmids in Enterobacteriaceae \[[@CR3]--[@CR6]\]. However, genomic hallmarks of the bacterial host reservoir for the *mcr*-*1*-harbouring plasmids remain unclear. Here we report on their genomic compositions.

After three *mcr*-*1*-positive *E. coli* isolates (E15004, E15015 and E15017) were successfully screened from the microbiota of clinical diarrhea patients \[[@CR7]\], we applied next-generation Illumina MiSeq sequencing to decode their genomic sequences. The pool of paired-end reads produced here were assembled with GS De Novo Assembler into a collection of contigs. Then the individual contigs were ordered into draft genomes with the prototypical strain of *E. coli* MG1655 as the reference (Fig. [1](#Fig1){ref-type="fig"}, S1). Relative to the paradigm version of *E. coli*, MG1655 (4,641,425 bp), the three *mcr*-*1*-positive clinical *E. coli* isolates exhibited variations in the size of sequenced genomes (i.e., 4,643,275 bp for strain E15004; 4,637,424 bp for strain E15015, and 4,780,540 bp for strain E15017) (Table S1). The values of their GC percentages are all approximately 50 % (Table S1), although the draft genomes identified several regions with a strong GC skew, indicative of novel insertions of genomic material.Fig. 1Genomics-based discovery of multidrug-resistant genes in the *mcr*-*1*-positive ST648 *E. coli* coproducing extended-spectrum β-lactamase. Circular comparison of the three sequenced genomes (E15004, E15015 and E15017) with the paradigm strain MG1655 as the reference. Individual rings range from 1 (inner ring) to 4 (outer ring). (Ring 1---red) Strain 15005 conservation plot. (Ring 2---green) Strain 15015 conservation plot. (Ring 3---blue) Strain 15015 conservation plot. (Ring 4---magenta/green) GC Skew of MG1655 reference genome \[(G−C)/(G+C)\] magenta \> 0, green \< 0

Further comparative genomics suggests that genetic heterogeneity is present in the three *mcr*-*1*-positive *E. coli* isolates (Fig. [1](#Fig1){ref-type="fig"}, S2). We retrieved the sequences of seven house-keeping genes (*adk*, *fumC*, *gyrB*, *icd*, *mdh*, *purA* and *recA*) from the above three sequenced genomes and subjected them to analyses of Multi-Locus Sequence Typing (MLST) (<http://mlst.warwick.ac.uk/mlst/dbs/Ecoli>). Unlike the epidemic spreading clone, *E. coli* ST131 that carried the *mcr*-*1* gene in Denmark \[[@CR8]\], the three *mcr*-*1*-harbouring clinical strains belong to different sequence types (i.e., E15004 is in ST40, E15015 is in ST642, and E15017 is in ST648) (Table [1](#Tab1){ref-type="table"}, Fig. S3), which is generally consistent with our findings from comparative genomics (Fig. [1](#Fig1){ref-type="fig"}, S2). The fact that *mcr*-*1*-harbouring *E. coli* isolates are classified into different sequence types argues that the dissemination of *mcr*-*1* colistin resistance gene is ongoing by clonal expansion \[[@CR9]\]. Given the fact that *E. coli* ST648 was associated with ESBL \[[@CR10], [@CR11]\] and two variants of New Delhi metallo-β-lactamase 1 (NDM-1), NDM-5 \[[@CR12]\] and NDM-7 \[[@CR13]\]), we thereby were interested in determining whether or not the genes of ESBL and NDM would also be found with the *mcr*-*1* gene in the ST648 strain, E15017. Table 1Diversified sequence types of the *mcr*-*1*-positive *E. coli* strains revealed by bacterial genomics sequencingStrainsAllelesSTST Complex*adkfumCgyrBicdmdhpurArecA*MG16551011439882ST98ST10 CplxE150046452620814ST40ST40 CplxE1501592333181186ST642ST278 CplxE15017924879670582ST648ST648 CplxGenotyping of the *E. coli* strains was conducted through extensive alignments of the seven house-keeping genes (*adk*, *fumC*, *gyrB*, *icd*, *mdh*, *purA* and *recA*) processed with the server of Multi-Locus Sequence Typing (MLST) (<http://mlst.warwick.ac.uk/mlst/dbs/Ecoli>)

Using ResFinder2.1, a newly-improved database for identifying antibiotic resistance genes (<https://cge.cbs.dtu.dk/services/ResFinder>), we screened the above three genomic sequences, as well as the remaining unordered contigs, which likely encode additional plasmids, for the presence of antibiotic resistance genes *esp*. ESBL and NDM-1 (and/or its variants). As anticipated, a 100 % identical *mcr*-*1* gene was observed in the unordered contigs in each of the three strains. NDM-1 variants were not found, which we then verified by PCR-based detection (not shown). Unexpectedly, no other antibiotic resistance gene besides *mcr*-*1* is found in the strain E15004 (ST40) (not shown), whereas multiple drug-resistance genes apart from *mcr*-*1* were identified in the unordered contigs from the other two strains, E15015 (ST642) and E15017 (ST648) (Table [2](#Tab2){ref-type="table"}, S2). In particular, the *blaCTX*-*M*-*15* gene that encodes ESBL was found to be present in the ST648 strain, E15017 (Table [2](#Tab2){ref-type="table"}). Additionally, we noted that the *mcr*-*1* and *blaCTX*-*M*-*15* are located inside distinct unordered contigs, suggesting the possibility that they are encoded on different plasmids. This represents the first example of a clinical clone of *E. coli* with a sequence type of ST648 that has the potential to spread MCR-1 colistin resistance together with ESBL resistance. Table 2Genome-wide screening of the extended-spectrum β-lactamase in the *mcr*-*1*-positive E15017 strain with multidrug resistance genesResistance genesLength (bp)ContigsFunctions/phenotypes*aadA5*789Contig_13Aminoglycoside adenyl-transferase AadA5, Aminoglycoside resistance*strA*804Contig_26Aminoglycoside resistance, aph(3")-Ib)*strB*837Contig_26Aminoglycoside resistance, aph(6)-Id*blaCTX-M-15*876Contig_26Extended-spectrum β-lactamase*blaTEM-1B*861Contig_26β-lactam resistance*mph(A)*906Contig_13Macrolide resistance*sul1*840Contig_13Sulphonamide resistance*dfrA17*474Contig_13Dihydrofolate reductase DfrA17, Trimethoprim resistance

In summary, our data provides genomic insights into three strains of *mcr*-*1*-positive *E*. *coli* with multiple drug resistance, which reveals the increasing possibility of ST648 becoming an epidemic vector for circulation/spread of the *mcr*-*1* colistin resistance gene in China. As the inter/intra-species dissemination of the *mcr*-*1* gene has been linked to the spread of other drug resistance including ESBL \[[@CR11]\] and NDM-1 variants \[[@CR12], [@CR13]\], our findings underscore the urgent need to modulate and control the use of colistin in veterinary/clinical practices, which might facilitate prevention of the further emergence of superbugs with multi-drug resistance.
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